SpaceX at Half Price, Anthropic in the Queue: The IPO Hype Machine Has a Math Problem

Business119 articles covering this story· 2026-06-01

SpaceX at Half Price, Anthropic in the Queue: The IPO Hype Machine Has a Math Problem

Artificial intelligenceOpenAIInitial public offeringUnited States dollarU.S. Securities and Exchange CommissionUnited States
SpaceX at Half Price, Anthropic in the Queue: The IPO Hype Machine Has a Math Problem
"CDL Lightning Round on General Intelligence" by jurvetson is licensed under CC BY 2.0. To view a copy of this license, visit https://creativecommons.org/licenses/by/2.0/.

There is a ritual to the modern mega-IPO that almost never changes. A private company spends years accumulating a valuation built on venture capital optimism, secondary market whispers, and the gravitational pull of a famous founder. Then, when it finally moves toward a public listing, the financial press fills with superlatives, retail investors crowd in, and the bankers collect their fees. What gets skipped — almost every time — is the sober arithmetic that comes after the confetti.

This week, that arithmetic arrived early, and it was not flattering.

Morningstar analysts published a valuation of SpaceX that placed the company at roughly half its most recent private market price — a figure that had ballooned to approximately $350 billion in late 2024 secondary transactions. Morningstar's estimate does not mean SpaceX is a bad business. It means the private market, where shares trade without the disclosure requirements or price discipline of public exchanges, had apparently run well ahead of what the fundamentals support. That is not a surprise to anyone who has studied the mechanics of late-stage private valuations, but it is the kind of thing that tends to get lost when a company's name is Elon Musk's rocket firm.

The analysts' guidance was direct: investors who want exposure to SpaceX should wait. Let the IPO excitement fade. Let more shares become available as lockup periods expire. Buy later, when price discovery has had time to do its actual job. This is textbook advice that contradicts the breathless urgency of IPO marketing — which is precisely why it rarely makes the front page.

Meanwhile, a second headline arrived almost simultaneously: Anthropic, the AI safety company spun out of OpenAI by former OpenAI executives, has filed confidential IPO paperwork with the SEC. A confidential filing means the prospectus is not yet public — a legal mechanism that allows companies to test the regulatory waters before exposing their financials to scrutiny. What we do not yet know is revenue trajectory, burn rate, customer concentration, or how the company books its substantial compute costs. What we do know is that Anthropic's most recent private funding rounds valued it at roughly $61 billion, and that the IPO, if it proceeds, is expected to rank among the largest in recent U.S. history.

The Anthropic story carries its own complications that a simple IPO filing frame tends to obscure. The company markets itself explicitly on AI safety principles — it was founded, in part, as a reaction to concerns about OpenAI's direction — yet it has accepted billions in investment from Amazon and Google, two companies whose competitive interests in AI are as sharp as any on earth. How that structural tension plays out in product decisions, research publication, and governance is a question no IPO prospectus will answer cleanly, but public shareholders will eventually be living inside that tension whether they understand it or not.

The broader backdrop here is a market that has been waiting, with unusual patience, for a wave of tech listings that the 2021–2022 rate-rise cycle effectively froze in place. SpaceX and Anthropic represent two of the most valuable private companies in the world. Their entries into public markets would unlock billions in paper gains for early investors and give retail buyers access to assets previously restricted to venture firms and sovereign wealth funds. That democratization narrative is real — and it is also, historically, the moment at which the widest distribution of risk occurs.

The SEC's role in all of this is worth watching. The agency has, under different administrations, moved between aggressive disclosure enforcement and a lighter touch with high-profile tech listings. A confidential filing buys Anthropic time and reduces early public scrutiny, which is entirely legal and entirely in the company's interest. It is not, however, in the interest of the retail investor trying to decide whether $61 billion reflects a real business or a moment in AI hype.

None of this means either company will be a bad investment. SpaceX's launch manifest, Starlink subscriber base, and government contract book represent genuine, durable revenue. Anthropic's Claude models compete at the frontier of a market with structural tailwinds measured in decades. The point is simpler than a buy or sell call: when independent analysts say a company is priced at twice what the fundamentals support, and the IPO machinery is already in motion, the person most likely to absorb that gap is the one who buys at the open. The bankers already know this. Now, at least, so do you.

See what people are saying about this story on X.